BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 1, 2025
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Feb. 26, 2016
View Archived Issues
Gloria Pharmaceuticals investing $40 million in Proteus Digital Health
HONG KONG — Harbin, China-based Gloria Pharmaceuticals Co Ltd plans to invest $40 million in U.S. digital medicine firm Proteus Digital Health Inc., of Redwood City, Calif., as part of its role in the firm's H round of financing.
Read More
Better biomarkers needed to assess OA therapies, but patient voice still missing
Read More
Precision medicine 1M volunteer cohort becoming a reality
Read More
FDA prods Custom Ultrasonics to pull its reprocessing units
Read More
FDA's cancer moonshot aims at toppling the drug and device silos
Read More
Appointments & advancements
Read More
Products
Read More
Other News to Note
Read More
Daily M&A
Read More
Financings
Read More
MDD Diag Extra
Read More
Diabetes discovery may lead to stem cell-based therapies
Read More
